Xinhua Healthcare (600587) 2024 Interim Report Review: The medical device sector's short-term pressure cost rate has been optimized
Xinhua Healthcare (600587): Double increase in revenue and profit can be expected to increase throughout the year
Xinhua Healthcare (600587): Looking at Xinhua Healthcare from the perspective of increased profit margins
Xinhua Healthcare (600587): Driven by Innovation and Accelerating Old State-owned Enterprises to Revitalize New Vitality
Xinhua Healthcare (600587): Focus on the main business, consolidate competitiveness, optimize structure and improve quality
Xinhua Healthcare (600587) 2023 Report Review: Product Structure Continues to Improve, and International Business Is Growing Rapidly
Xinhua Healthcare (600587) 2023 Performance Review: Profitability Continues to Improve Rapid Growth in International Business
Xinhua Healthcare (600587) Annual Report Review Report: Continued optimization of revenue structure, impairment affects profit performance, and a high percentage of dividends give back to shareholders
Xinhua Healthcare (600587) In-depth Research Report: Established State-owned Enterprises Set Sail Again
Xinhua Medical (600587) '23 Three Quarterly Report Review: The Double Driving Margin of Medical Devices and Pharmaceutical Equipment Continues to Increase
Xinhua Healthcare (600587): Profitability Continues to Increase and Contribute to New Product Launches
Xinhua Healthcare (600587): Focus on the continuous improvement of profitability of the main business
Xinhua Healthcare (600587) 2023Q3 Review Report: Focus on the main business to see results and improve profitability
Xinhua Healthcare (600587): Business focus and continuous improvement in high-end iterative profitability
Xinhua Healthcare (600587): Business focus and continuous improvement in high-end iterative profitability
Xinhua Healthcare (600587): Focus on the main business, enhance Maori, expand overseas business rapidly
Xinhua Healthcare (600587): Focusing on the current vitality of the main business, internal and external strength exceeding expectations
Xinhua Healthcare (600587): Under a high base, performance growth is steady, gross margin continues to increase, and the results of the internationalization strategy are beginning to show
Xinhua Healthcare (600587): An old leader in medical devices under the acceleration of national reform
Research Report Nuggets 丨 CaiTong Securities: Xinhua Healthcare's Profitability Has Been Significantly Increased, New Businesses in the Pharmaceutical Equipment Sector Made Breakthrough Progress
No Data